Home » Topics » BioWorld Science

BioWorld Science
RSS

M-9657 shows mesothelin-dependent antitumoral activity in vivo

Nov. 29, 2021

Discovery of the novel BCL6 BTB-specific inhibitor, AP-4-287

Nov. 29, 2021

Targeting senescent cells may fight insulin resistance

Nov. 29, 2021

KCC2 shows promise as therapeutic target for neonatal seizures

Nov. 29, 2021

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Eli Lilly divulges new MRGPRX1 agonists

Nov. 29, 2021

Polycystic ovary syndrome murine model reveals CYP17 involvement

Nov. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026